Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Destefano

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Obstetrics and Gynecology|October 8, 2015
Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in PregnancyLakshmi Sukumaran, Natalie L McCarthy, Elyse O Kharbanda, et al.
Pediatrics|May 21, 2014
Timely versus delayed early childhood vaccination and seizuresSimon J Hambidge, Sophia R Newcomer, Komal J Narwaney, et al.
The New England Journal of Medicine|September 28, 2007
Early thimerosal exposure and neuropsychological outcomes at 7 to 10 yearsWilliam W Thompson, Cristofer Price, Barbara Goodson, et al.
JAMA|October 27, 2015
Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing ImmunizationsLakshmi Sukumaran, Natalie L McCarthy, Elyse O Kharbanda, et al.
American Journal of Preventive Medicine|July 20, 2011
H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink projectGrace M Lee, Sharon K Greene, Eric S Weintraub, et al.
Pediatrics|November 20, 2019
Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus VaccineJames G Donahue, Burney A Kieke, Edwin M Lewis, et al.
Vaccine|September 22, 2019
Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15James G Donahue, Burney A Kieke, Jennifer P King, et al.
JAMA|October 26, 2006
Safety of trivalent inactivated influenza vaccine in children 6 to 23 months oldSimon J Hambidge, Jason M Glanz, Eric K France, et al.
JAMA|September 3, 2021
Surveillance for Adverse Events After COVID-19 mRNA VaccinationNicola P Klein, Ned Lewis, Kristin Goddard, et al.
American Journal of Epidemiology|May 15, 2012
Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million AmericansMatthew E Wise, Melissa Viray, James J Sejvar, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Obstetrics and Gynecology|October 8, 2015
Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in PregnancyLakshmi Sukumaran, Natalie L McCarthy, Elyse O Kharbanda, et al.
Pediatrics|May 21, 2014
Timely versus delayed early childhood vaccination and seizuresSimon J Hambidge, Sophia R Newcomer, Komal J Narwaney, et al.
The New England Journal of Medicine|September 28, 2007
Early thimerosal exposure and neuropsychological outcomes at 7 to 10 yearsWilliam W Thompson, Cristofer Price, Barbara Goodson, et al.
JAMA|October 27, 2015
Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing ImmunizationsLakshmi Sukumaran, Natalie L McCarthy, Elyse O Kharbanda, et al.
American Journal of Preventive Medicine|July 20, 2011
H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink projectGrace M Lee, Sharon K Greene, Eric S Weintraub, et al.
Pediatrics|November 20, 2019
Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus VaccineJames G Donahue, Burney A Kieke, Edwin M Lewis, et al.
Vaccine|September 22, 2019
Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15James G Donahue, Burney A Kieke, Jennifer P King, et al.
JAMA|October 26, 2006
Safety of trivalent inactivated influenza vaccine in children 6 to 23 months oldSimon J Hambidge, Jason M Glanz, Eric K France, et al.
JAMA|September 3, 2021
Surveillance for Adverse Events After COVID-19 mRNA VaccinationNicola P Klein, Ned Lewis, Kristin Goddard, et al.
American Journal of Epidemiology|May 15, 2012
Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million AmericansMatthew E Wise, Melissa Viray, James J Sejvar, et al.
Pageof 11